Sandra Gottschling

522 total citations
16 papers, 431 citations indexed

About

Sandra Gottschling is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Sandra Gottschling has authored 16 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Sandra Gottschling's work include Cancer Cells and Metastasis (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Mesenchymal stem cell research (3 papers). Sandra Gottschling is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Mesenchymal stem cell research (3 papers). Sandra Gottschling collaborates with scholars based in Germany, United Kingdom and Poland. Sandra Gottschling's co-authors include Philipp A. Schnabel, Esther Herpel, Felix Herth, Michael Thomas, Thomas Muley, Michael Meister, U. Krause, Anja Seckinger, Rainer Saffrich and Anthony D. Ho and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of the New York Academy of Sciences.

In The Last Decade

Sandra Gottschling

16 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Gottschling Germany 11 189 154 107 101 91 16 431
Christopher Riley United States 8 177 0.9× 179 1.2× 117 1.1× 58 0.6× 145 1.6× 11 514
Maksim Yezhelyev Germany 7 183 1.0× 245 1.6× 61 0.6× 56 0.6× 48 0.5× 7 429
James Dean United Kingdom 8 111 0.6× 212 1.4× 134 1.3× 79 0.8× 103 1.1× 24 505
Elisa Pellegrino Italy 12 273 1.4× 325 2.1× 123 1.1× 153 1.5× 153 1.7× 21 742
Julie Madden United Kingdom 9 212 1.1× 214 1.4× 49 0.5× 82 0.8× 110 1.2× 14 502
Ondřej Havránek Czechia 13 154 0.8× 240 1.6× 47 0.4× 86 0.9× 85 0.9× 45 538
Bastien Kaniewski France 10 102 0.5× 235 1.5× 47 0.4× 90 0.9× 66 0.7× 12 429
S. Öhl Germany 13 234 1.2× 216 1.4× 106 1.0× 114 1.1× 179 2.0× 19 778
Caroline Wallace United States 11 275 1.5× 237 1.5× 54 0.5× 79 0.8× 232 2.5× 13 628

Countries citing papers authored by Sandra Gottschling

Since Specialization
Citations

This map shows the geographic impact of Sandra Gottschling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Gottschling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Gottschling more than expected).

Fields of papers citing papers by Sandra Gottschling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Gottschling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Gottschling. The network helps show where Sandra Gottschling may publish in the future.

Co-authorship network of co-authors of Sandra Gottschling

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Gottschling. A scholar is included among the top collaborators of Sandra Gottschling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Gottschling. Sandra Gottschling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gottschling, Sandra, Martin Granzow, Ruprecht Kuner, et al.. (2013). Mesenchymal stem cells in non-small cell lung cancer—Different from others? Insights from comparative molecular and functional analyses. Lung Cancer. 80(1). 19–29. 41 indexed citations
2.
Gottschling, Sandra, Philipp A. Schnabel, Felix Herth, & Esther Herpel. (2013). Are we missing the target? Cancer stem cells and drug resistance in non-small cell lung cancer.. PubMed. 9(5). 275–86. 50 indexed citations
3.
Gottschling, Sandra, Katrin Jensen, Felix Herth, et al.. (2013). Lack of prognostic significance of neuroendocrine differentiation and stem cell antigen co-expression in resected early-stage non-small cell lung cancer.. PubMed. 33(3). 981–90. 13 indexed citations
4.
Gottschling, Sandra, Katrin Jensen, Arne Warth, et al.. (2012). Stage-specific embryonic antigen-4is expressed in basaloid lung cancer and associated with poor prognosis. European Respiratory Journal. 41(3). 656–663. 24 indexed citations
5.
Gottschling, Sandra, Esther Herpel, Wilfried Eberhardt, et al.. (2012). The gefitinib long-term responder (LTR)—A cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP). Lung Cancer. 77(1). 183–191. 12 indexed citations
6.
Gottschling, Sandra, Roland Penzel, Tanja Pelz, et al.. (2011). KRAS-Mutation Positive, Metastatic Tonsil Carcinoma With Cancer Stem-Like Cell Features and Long-Term Response to Gefitinib: A Case Report and Review of the Literature. Journal of Clinical Oncology. 29(21). e616–e619. 6 indexed citations
7.
Herpel, Esther, Katrin Jensen, Thomas Muley, et al.. (2011). The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer.. PubMed. 31(12). 4491–500. 39 indexed citations
8.
Gottschling, Sandra, Anna Jauch, Ruprecht Kuner, et al.. (2011). Establishment and comparative characterization of novel squamous cell non-small cell lung cancer cell lines and their corresponding tumor tissue. Lung Cancer. 75(1). 45–57. 25 indexed citations
9.
Gottschling, Sandra, Martin Granzow, Ruprecht Kuner, et al.. (2009). The Individuality of Tumour-Stroma Interaction in Non-Small Cell Lung Cancer: Insights from Funtional and Molecular Analysis. Pneumologie. 63(S 01). 1 indexed citations
10.
Reinmuth, Niels, Anna Jauch, Elizabeth C. Xu, et al.. (2008). Correlation of EGFR mutations with chromosomal alterations and expression of EGFR, ErbB3 and VEGF in tumor samples of lung adenocarcinoma patients. Lung Cancer. 62(2). 193–201. 42 indexed citations
11.
Gottschling, Sandra, Volker Eckstein, Rainer Saffrich, et al.. (2007). Primitive and committed human hematopoietic progenitor cells interact with primary murine neural cells and are induced to undergo self-renewing cell divisions. Experimental Hematology. 35(12). 1858–1871. 7 indexed citations
12.
13.
Wuchter, Patrick, Judit Boda‐Heggemann, Beate K. Straub, et al.. (2005). Molecular Characterization of Unique Junctional Complexes as Communication Pathways among Mesenchymal Stem Cells.. Blood. 106(11). 1399–1399. 1 indexed citations
14.
Straub, Beate K., Volker Eckstein, Christine Gründ, et al.. (2004). Expression of Complex Junction Proteins in Hematopoietic Progenitor Cells.. Blood. 104(11). 1282–1282. 1 indexed citations
15.
Handgretinger, Rupert, Peter Lang, Michael Schumm, et al.. (2001). Immunological Aspects of Haploidentical Stem Cell Transplantation in Children. Annals of the New York Academy of Sciences. 938(1). 340–358. 30 indexed citations
16.
Klouche, Mariam, Sandra Gottschling, Wolfgang Hell, et al.. (1998). Atherogenic Properties of Enzymatically Degraded LDL. Arteriosclerosis Thrombosis and Vascular Biology. 18(9). 1376–1385. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher Riley Breakdown of academic impact, for papers by Maksim Yezhelyev Breakdown of academic impact, for papers by James Dean Breakdown of academic impact, for papers by Elisa Pellegrino Breakdown of academic impact, for papers by Julie Madden Breakdown of academic impact, for papers by Ondřej Havránek Breakdown of academic impact, for papers by Bastien Kaniewski Breakdown of academic impact, for papers by S. Öhl Breakdown of academic impact, for papers by Caroline Wallace
Rankless by CCL
2026